{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T15:29:33Z","timestamp":1771687773923,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12328-015-0566-y","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T18:31:26Z","timestamp":1427913086000},"page":"116-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment"],"prefix":"10.1007","volume":"8","author":[{"given":"Shunichi","family":"Yanai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aritsune","family":"Ooho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"566_CR1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390.","journal-title":"N Engl J Med."},{"key":"566_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2009","unstructured":"Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25\u201334.","journal-title":"Lancet Oncol"},{"key":"566_CR3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(09)70222-0","volume":"10","author":"Y Je","year":"2009","unstructured":"Je Y, Schutz FA, Choueiri TK. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. Lancet Oncol. 2009;10:967\u201374.","journal-title":"Lancet Oncol"},{"key":"566_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2004-814193","volume":"36","author":"H Toyoda","year":"2004","unstructured":"Toyoda H, Jaramillo E, Mukai K, et al. Treatment of radiation-induced hemorrhagic duodenitis with argon plasma coagulation. Endoscopy. 2004;36:192.","journal-title":"Endoscopy"},{"key":"566_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2013.05.012","volume":"87","author":"BM Barney","year":"2013","unstructured":"Barney BM, Markovic SN, Laack NN, et al. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2013;87:73\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"566_CR6","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","volume":"96","author":"T Kamba","year":"2007","unstructured":"Kamba T, McDonald DM. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer. 2007;96:1788\u201395.","journal-title":"Br J Cancer"},{"key":"566_CR7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cncr.24029","volume":"115","author":"T Yau","year":"2009","unstructured":"Yau T, Chan P, Ng KK, et al. Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response. Cancer. 2009;115:428\u201336.","journal-title":"Cancer"},{"key":"566_CR8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ijrobp.2010.07.1986","volume":"81","author":"YE Chon","year":"2011","unstructured":"Chon YE, Seong J, Kim BK, et al. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. Int J Radiat Oncol Biol Phys. 2011;81:1343\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"566_CR9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1572-0241.2002.05602.x","volume":"97","author":"R Shudo","year":"2002","unstructured":"Shudo R, Yazaki Y, Sakurai S, et al. Duodenal erosions, a common and distinctive feature of portal hypertensive duodenopathy. Am J Gastroenterol. 2002;97:867\u201373.","journal-title":"Am J Gastroenterol"},{"key":"566_CR10","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.1055\/s-0032-1326641","volume":"45","author":"Y Takahashi","year":"2013","unstructured":"Takahashi Y, Fukunishi S, Nishikawa T, et al. Small-intestinal hemorrhage caused by treatment with sorafenib for hepatocellular carcinoma and diagnosed by capsule endoscopy. Endoscopy. 2013;45:E179\u201380.","journal-title":"Endoscopy"},{"key":"566_CR11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1752-1947-8-72","volume":"8","author":"HY Kang","year":"2014","unstructured":"Kang HY, Moon SH, Song IH. A unique bleeding-related complication of sorafenib, a tyrosine kinase inhibitor, in advanced hepatocellular carcinoma: a case report. J Med Case Rep. 2014;8:72.","journal-title":"J Med Case Rep"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-015-0566-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-015-0566-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-015-0566-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:57:30Z","timestamp":1559462250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-015-0566-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1007\/s12328-015-0566-y","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}